Md. biotech Adaptive Phage Therapeutics advances fight to wipe out superbugs in cystic fibrosis
The National Institutes of Health is funding its latest clinical trial. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 12, 2023 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news
Health Secretary Steve Barclay gets confronted by mother of little girl with cystic fibrosis
The Health Secretary met with Sarah Pinnington-Auld at King's College Hospital in London today. her three-year-old daughter Lucy suffers with the genetic condition cystic fibrosis. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2022 Category: Consumer Health News Source Type: news
Driver of cystic fibrosis lung inflammation yields target for treatment
Yale researchers have uncovered a driver of the chronic inflammation that damages lungs in cystic fibrosis. It could be a target for treatment. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 13, 2022 Category: Universities & Medical Training Source Type: news
Genome sequencing trial to test benefits of identifying genetic diseases at birth
Study with 100,000 babies to look at faster diagnosis of rare conditions and how genetic data might be usedGenomics England is to test whether sequencing babies ’ genomes at birth could help speed up the diagnosis of about 200 rare genetic diseases, and ensure faster access to treatment.The study, which will sequence the genomes of 100,000 babies over the next two years, will explore the cost-effectiveness of the approach, as well as how willing new parents are to accept it.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 13, 2022 Category: Science Authors: Linda Geddes Tags: Genetics Children's health Medical research UK news Science Biology Cystic fibrosis Sickle cell disease Source Type: news
Teen Marijuana Poisonings Have Skyrocketed. How to Keep Your Child Safe
Cannabis might still be banned federally, but most U.S. adults (88%) say it should be legal, according to a Nov. 22 Pew Research Center poll—and in nearly half of states, it is. Like any psychoactive substance, however, cannabis comes with some health risks, especially for children and adolescents.
Over the last two decades, cannabis cases have flooded hotlines U.S. Poison Control Centers—facilities across the country staffed by toxicology experts who provide 24-hour-a-day guidance to both the general public and health professionals. According to a new study published in Clinical Toxicology on Dec. 5, which rev...
Source: TIME: Health - December 5, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized healthscienceclimate Public Health Source Type: news
Nabriva stock up after firm's antibiotic shows promise as a potential cystic fibrosis treatment
A Fort Washington pharmaceutical company's stock opened up 9% Monday after it posted positive early stage clinical trial results from testing of its antibiotic Xenleta as a potential treatment for cystic fibrosis.
Nabriva Therapeutics' stock was trading up about 13% at $2.45 per share in early morning trading.
Cystic fibrosis is a progressive, genetic disease that causes severe damage to the lungs, digestive system, and other organs. It can cause frequent lung infections including pneumonia or … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Authors: John George Source Type: news
PASTE Tool Inserts large DNA Sequences at Desired Cell Sites
The new technique, known as PASTE, could hold promise for treating diseases that are caused by defective genes with a large number of mutations, such as cystic fibrosis (Source: Disabled World)
Source: Disabled World - November 26, 2022 Category: Disability Tags: CRISPR Research News Source Type: news
Bristol computational chemist wins funding to advance drug discovery efforts to treat addiction, pain, and cystic fibrosis
A trailblazing chemist from the University of Bristol has been awarded a prestigious fellowship to help progress vital research, which could help patients overcome addiction, manage chronic pain, and treat cystic fibrosis. (Source: University of Bristol news)
Source: University of Bristol news - November 2, 2022 Category: Universities & Medical Training Tags: Announcements, International, Postgraduate, Research, Health; Faculty of Science, School of Chemistry, Faculty of Science; Press Release Source Type: news
Challenged Urine Bicarbonate Excretion Tied to CFTR Function in Cystic Fibrosis
TUESDAY, Nov. 1, 2022 -- For patients with cystic fibrosis, challenged urine bicarbonate excretion may be a marker for cystic fibrosis transmembrane conductance regulator (CFTR) function, according to a study published online Nov. 1 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 1, 2022 Category: Pharmaceuticals Source Type: news
Simple Urine Test Could Improve Cystic Fibrosis Treatment Simple Urine Test Could Improve Cystic Fibrosis Treatment
A measure of bicarbonate in urine was associated with both disease severity and response to treatment in a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
Cystic Fibrosis Screening Often Misses Black, Hispanic Babies
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 31, 2022 Category: Respiratory Medicine Tags: Pulmonology, News, Source Type: news
Newborn Screening for Cystic Fibrosis Less Accurate in Minorities
MONDAY, Oct. 31, 2022 -- Cystic fibrosis transmembrane conductance regulator (CFTR) variant panels have lower detection rates when used for newborn screening (NBS) in racial and ethnic-minority groups, according to a study published online Oct. 13... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2022 Category: Pharmaceuticals Source Type: news
Cystic Fibrosis Screening Often Misses Black, Hispanic Babies
MONDAY, Oct. 31, 2022 – While early diagnosis of cystic fibrosis can prevent permanent lung damage, newborn screening often looks only for genetic mutations more common in white people than those found in people of color, a new study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2022 Category: General Medicine Source Type: news
Long-Term Xeljanz for UC; AGA Drops Obesity Drug Guidelines; PPIs & Cystic Fibrosis?
(MedPage Today) -- Health-related quality-of-life outcomes continued to be favorable with maintenance tofacitinib (Xeljanz) for ulcerative colitis (UC) during up to 6 years of follow-up, regardless of treatment history, responder status, or remission... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 20, 2022 Category: Gastroenterology Source Type: news
